Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Basic Science Posters (Oncology)

  • You have access
    Enhanced metabolic elimination radioactivity associated with DOTA chelates from radioimmunoconjugates.
    Ryan Simms, John Forbes, Sean Collens, Matthew Moran, Stuart Mahoney, John Valliant and Eric Burak
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1281;
  • You have access
    A comparison of in vivo stability of Ga-68 labeled peptide conjugate for targeting VPAC receptors.
    Pardeep Kumar, Sushil Tripathi and Mathew Thakur
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1298;
  • You have access
    Evaluation of the correlation between expression of ATAD2 and uptake value of 18F-FDG PET/CT imaging in human lung adenocarcinoma
    Yaming Li and Tong Sun
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1295;
  • You have access
    Imaging lymphatic delivery of anti CTLA-4 and its anti-tumor response in a non-immunogenic breast cancer model
    Sunkuk Kwon, Fred Velasquez, Russell Ross, Wen Hwu and Eva Sevick
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1297;
  • You have access
    Ultra-low dose Na18F using a digital PET/CT in a preclinical phase I study - How low can we go?
    Maria Menendez, Richard Moore, Katherine Binzel, Michael Friel, Jun Zhang and Michael Knopp
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1283;
  • You have access
    Interstitial Therapy of Feline Sarcoma using an Injectable Y-90-Polymer Composite (Radiogel)
    Darrell Fisher, Janean Fidel and Megan Duffy
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1257;
  • You have access
    Precision Bone PET imaging: Ultra-high definition image reconstruction enabled by digital PET/CT in a pre-clinical canine model
    Maria Menendez, Richard Moore, Katherine Binzel, Michael Friel, Jun Zhang and Michael Knopp
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1284;
  • You have access
    Characterization of tumor-associated neovasculature in HCC
    Olga Sergeeva, Yifan Zhang, Maxim Sergeev, Wuxian Shi, Sandra Sexton, Renuka Iyer, James Basilion, Norbert Avril and Zhenghong Lee
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1274;
  • You have access
    Species difference of astatine-211 uptakes in the whole body distribution: preclinical study using treated At-solution.
    Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuwei Liu, Yoshifumi Shirakami, Atsushi Toyoshima, Mitsuaki Tatsumi, Eku Shimosegawa, Mitsuhiro Fukuda, Atsushi Shinohara and Jun Hatazawa
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1269;
  • You have access
    Targeting VPAC1 receptors for imaging glioblastoma
    Sushil Tripathi, Rhonda Kean, D. Craig Hooper, Yuan Yuan Jin, Eric Wickstrom and Mathew Thakur
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1262;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 12
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire